Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients

Conditions

• Feasibility, Tolerance and Safety of VR Delivery in an Adult ICU

Eligibility Criteria

Sex

ALL

Age

N/A - N/A

Healthy Volunteers

Accepted

Interventions

• Virtual reality (VR) therapy — DEVICE
  VR sessions will use a commercially available headset with non-interactive, immersive content displaying calming nature-based content (e.g., ocean/beach scenes, forests, mountains) delivered through a commercially available VR application

Study Details

This is a pilot feasibility study examining the use of immersive virtual reality (VR) in adult intensive care unit (ICU) patients. The study evaluates whether brief, non-interactive VR sessions delivered using a commercially available standalone head-mounted display with calming, nature-based content can be delivered safely and effectively within routine SICU workflow. Exploratory objectives assess whether VR sessions are associated with changes in anxiety, agitation, delirium, pain, and sedative medication requirements. This research is not intended to evaluate the safety or effectiveness of the headset and/or the specific VR software used for the research

Key Dates

Start date

Jun 2, 2026

Status verified

Jun 2026

Primary completion

Sep 30, 2026

Completion

Sep 30, 2026

Study Design

Enrollment

30 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Arms

• Experimental: VR Intervention
  Critically ill patients

Primary Outcome Measure

Feasibility of Intervention Measure (FIM) [ Time Frame: From time of enrollment to end of intervention at 3 days ]

Central Contacts

• Pauline H Go, MD
  717-531-5429
  [email protected]
• Aleksandr Davtyan
  [email protected]

Locations (1)

Find similar trials in Hershey, PA